M
Medican Enterprises Inc
OTC:MDCN
Medican Enterprises Inc
OTC:MDCN
Price:
0.0001
USD
Market Closed
Market Cap:
$28.8k
Relative Value
There is not enough data to reliably calculate the relative value of MDCN.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MDCN
Relative Value
Base Case
Not Available
Multiples Across Competitors
MDCN Competitors Multiples
Medican Enterprises Inc Competitors
Medican Enterprises Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
M
|
Medican Enterprises Inc
OTC:MDCN
|
28.8k USD | 0 | -0 | -0.2 | -0.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
952.7B USD | 14.6 | 46.2 | 31.1 | 33.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
584.1B USD | 6.2 | 21.8 | 15.1 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
268.9B CHF | 4.4 | 20.9 | 12.3 | 13.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
237.2B CHF | 5.4 | 21.8 | 13.5 | 17.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
227.8B GBP | 5.2 | 29.9 | 16.6 | 23.3 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
289.8B USD | 4.5 | 15.9 | 9.9 | 12 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.7 | 11.1 | 8.2 | 9.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.4B USD | 2.4 | 19.6 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122B USD | 2.5 | 17.3 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
